Whom to Evaluate for Cardiac Amyloidosis: ASNC/Multisocietal Expert Consensus Recommendations
Date: December 11, 2019
Time: 12:00PM - 01:00PM
You must be registered to participate!
Learning Objectives:
- Review the Expert Consensus Recommendations (ECR) for cardiac amyloidosis imaging in clinical practice
- Demonstrate appropriate use of the ECR in clinical practice using multiple case studies
- Provide clinical insights to diagnosis and management of cardiac amyloidosis
Agenda
- Overview of Expert Consensus Recommendations for Multimodality Imaging in Cardiac Amyloidosis
- Case Studies
- Identifying cardiac involvement: No cardiac symptoms
- Screening for cardiac amyloidosis: New symptomatic heart failure
- Evaluation of biopsy proven AL amyloidosis
- Evaluation of biopsy proven ATTR amyloidosis
- Follow-up testing: New or worsening cardiac symptoms
- Other clinical conditions associated with amyloidosis
- Summary and recommendations
This activity is sponsored by Pfizer. No CME/CE credit is available for this webinar.
Moderators:
Speakers:
-
Jamieson M. Bourque, MD, MHS, Associate Professor of Medicine and Radiology, Medical Director of Nuclear Cardiology and the Stress Laboratory, University of Virginia Health Systems
-
Brett W. Sperry, MD, Saint Luke's Mid America Heart Institute, Kansas City, MO
-
Mathew S. Maurer, MD, New York Presbyterian
-
Rodney H. Falk, MD, Associate Professor, Harvard Medical School, Cardiovascular Medicine, Director, Cardiac Amyloidosis Program Brigham and Women's Hospital Boston, MA